Regulations/Policies - Page 3 of 27 - Express Pharma

DCGI issues advisory about Digene Gel following Abbott’s voluntary recall

US FDA places partial clinical hold on Gilead’s studies on Magrolimab for AML treatment

Industry backlash may reshape EU compulsory pharma licensing reform: GlobalData

Pharma to face more pricing pain as new legislation expands scope of Inflation Reduction Act: GlobalData

143 pharma companies get show cause notices from CDSCO post inspections

WHO flags Cold Out cough syrup over higher limits of diethylene and ethylene glycol

Marksans announces completion US FDA PADE inspection

Ten stakeholders write to Health Minister to recall New Drugs, Cosmetics & Medical Devices Bill

Centhaquine set to enter US-FDA approved Phase 3 clinical trial in US and Europe

Lupin gets EIR from US FDA for Pithampur Unit-2 facility